Page 1 of Clinical Trials for Exelixis [SPONSOR-COLLABORATORS], 33 Total Matches
- 1Active, not recruitingLast Updated: June 2, 2011Condition(s): Lymphoma; Cancer; Thyroid Carcinoma
- 2TerminatedLast Updated: April 4, 2011Condition(s): Chronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
- 3TerminatedLast Updated: October 1, 2010Condition(s): Cancer; Lymphoma
- 4Active, not recruitingLast Updated: May 24, 2012Condition(s): Papillary Thyroid Cancer; Follicular Thyroid Cancer; Huerthle Cell Thyroid Cancer; Renal Cell Carcinoma
- 5Active, not recruitingLast Updated: May 24, 2012Condition(s): Solid Tumors; Cancer
- 6Not yet recruitingLast Updated: May 23, 2012Condition(s): Prostate Cancer; Castration Resistant Prostate Cancer; Pain; Prostatic Neoplasms
- 7TerminatedLast Updated: October 1, 2010Condition(s): Polycythemia Vera
- 8Active, not recruitingLast Updated: May 24, 2012Condition(s): Thyroid Cancer
- 9CompletedLast Updated: August 14, 2008Condition(s): Cancer
- 10CompletedLast Updated: August 9, 2010Condition(s): Gastrointestinal Stromal Tumors; Gastrointestinal Neoplasms
- 11TerminatedLast Updated: April 4, 2011Condition(s): Cancer; Lymphoma
- 12RecruitingLast Updated: May 24, 2012Condition(s): Prostate Cancer; Castration Resistant Prostate Cancer; Pain; Prostatic Neoplasms
- 13Active, not recruitingLast Updated: June 2, 2011Condition(s): Carcinoma, Non-Small-Cell Lung
- 14RecruitingLast Updated: May 24, 2012Condition(s): Solid Tumors; Cancer
- 15RecruitingLast Updated: May 24, 2012Condition(s): Healthy; Hepatic Impairment
- 16Completed
- 17TerminatedLast Updated: April 4, 2011Condition(s): Myeloproliferative Disorders; Myelofibrosis; Polycythemia Vera; Thrombocythemia, Essential
- 18SuspendedLast Updated: June 2, 2008Condition(s): Cancer; Solid Tumors
- 19CompletedLast Updated: October 11, 2011Condition(s): Cancer; Non-small-cell Lung Cancer; Colorectal Cancer; Papillary Thyroid Cancer; Melanoma
- 20TerminatedLast Updated: June 2, 2008Condition(s): Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Exelixis
